M-RISE Strategy

“We are focusing on early treatments delivered by bystanders and first responders, which we believe will have the greatest therapeutic benefits for cardiac arrest patients,” Robert Neumar, MD, PhD, M-RISE Director says. “By optimizing the timing of bystander intervention and the therapies they can provide, we hope to significantly increase the number of out-of-hospital cardiac arrest patients that survive to lead normal lives.”


This is the first time the University of Michigan has received research network funding from the American Heart Association (AHA) and the M-RISE team is eager to begin its work.

The M-RISE team will provide their translation accelerator research platform to other centers that have new therapies and interventions they need to synergistically develop, test and implement. M-RISE will also work with the other AHA centers in each research project to share data and offer support and consult.

“We envision a future in which the AHA goal of doubling cardiac arrest survival is achieved, which could save 100,000 lives each year in the U.S. alone,” Neumar says. “M-RISE will allow us to become one step closer to achieving that goal.”